Cardioprotección perioperatoria
Perioperative cardioprotection.
Leung MK, Irwin MG.
Department of Anaesthesiology, University of Hong Kong / Queen Mary Hospital Hong Kong SAR, China.
F1000Prime Rep. 2013;5:7. doi: 10.12703/P5-7. Epub 2013 Mar 4.
Abstract
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no "magic bullet", pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/pdf/medrep-05-07.pdf
Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org
Perioperative cardioprotection.
Leung MK, Irwin MG.
Department of Anaesthesiology, University of Hong Kong / Queen Mary Hospital Hong Kong SAR, China.
F1000Prime Rep. 2013;5:7. doi: 10.12703/P5-7. Epub 2013 Mar 4.
Abstract
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no "magic bullet", pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/pdf/medrep-05-07.pdf
Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org
No hay comentarios:
Publicar un comentario